A new study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

The cancer diagnostics market is on the verge of explosion, as the researcher’s approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Coverage

France
Germany
Italy
Japan
Spain
UK
USA

Worldwide Market Overview

- Five-year test volume and sales projections by country.

- Comprehensive market segmentation analysis, including review
  of the market dynamics, structure, size, growth and major suppliers
  by country.

- Estimated universe of laboratories performing cancer diagnostic testing
  by country.

- Cancer statistics, etiology and recent developments in the
  U.S., Europe, and Asia.

Over 200 Current and Emerging Cancer Diagnostic Test

- Oncogenes
- Biochemical Markers
- Growth Factors
- Colony Stimulating Factors
- Hormones
- Immunohistochemical Stains
- Lymphokines

Competitive Strategies

- Strategic assessments of major suppliers 
and start-up firms developing innovative cancer diagnostic 
technologies and products, including their sales, 
product portfolios, marketing tactics, collaborative
arrangements, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott
   - AdnaGen
   - Becton Dickinson
   - Biomedical Diagnostics
   - bioMerieux 
   - Bio-Rad
   - CellSearch
   - Enzo Biochem
   - Fujirebio
   - Guided Therapeutics
   - OncoLab
   - Roche
   - Sequenom 
   - Siemens Healthcare
   - Targeted Diagnostics & Therapeutics
   - Thermo Fisher

Related Reports:

Cancer Diagnostics Market, 2019-2023: Supplier Shares by Test and Country, Emerging Tests, Technology Assessment, Instrumentation Review, Country Volume and Sales Forecasts, Strategic Profiles of Leading Suppliers

Category:  Healthcare Market Research

Contact Details:

Aarkstore Enterprise

+917710006788 | contact@aarkstore.com | www.aarkstore.com